Clinical trial
S(+)-Ibuprofen Effects on Asprin Treated Volunteers
NCT00442585 · Gebro Pharma GmbH, Industry · Completed
Key facts
| NCT number | NCT00442585 |
|---|---|
| Title | S(+)-Ibuprofen Effects on Asprin Treated Volunteers |
| Official title | Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers |
| Lead sponsor | Gebro Pharma GmbH, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Drug Interactions |
| Intervention type | Drug |
| Interventions | S(+)-ibuprofen |
| Enrollment | 72 |
| Start date | Sep 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 13, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: